| Research groups |
Chief Director |
Directors |
|---|---|---|
|
Supportive care for toxicities arising from cancer treatment |
Tomoya Yokota |
Hirotoshi Iihara / Yohei Iimura / Hiroshi Ishiguro / Sadamoto Zenda / Michio Nakamura |
| Yoshihisa Matsumoto |
Hiroto Ishiki / Jun Kako / Ryoichi Sadahiro /Daisuke fujisawa / Tomofumi Miura / Masaki Mori |
|
|
Maiko Fujimori |
Tatsuo Akechi / Masatoshi Inagaki /Kazuhiro Yoshiuchi /Taichi Shimazu |
Supportive care for toxicities arising from cancer treatment
In cancer care, a variety of interventions, including medications and procedures, are used to alleviate toxicities arising from primary cancer treatments, such as surgery, anticancer drug treatment, and radiation therapy. These toxicities include gastrointestinal symptoms, skin disorders, and other treatment-related adverse effects. Such interventions are generally referred to as supportive care. However, not all supportive care interventions are necessarily supported by sufficient scientific evidence.
The Supportive Care Group actively supports interventional research in cancer supportive care with the aim of establishing standard treatments based on high-quality clinical research.
Palliative care for symptoms arising from cancer
A variety of medications, procedures, and forms of care are provided as palliative care to relieve distressing symptoms arising from the disease itself in patients with cancer. However, many of these interventions are based largely on clinical experience and lack sufficient scientific evidence regarding their safety and efficacy. Therefore, establishing standard treatments based on high-quality clinical research is also considered an important international priority in palliative care.
The Palliative Care Group actively supports interventional research, particularly research on treatments and care for various distressing symptoms arising from the disease itself.
Psychosocial and Survivorship Care
Psychosocial and survivorship care covers all forms of support related to human behavior. This includes support for cancer survivors, their families, healthcare and support professionals, and society as a whole. In addition to clinical research on support methods for individual survivors, we also consider social interventions that target the community as a whole. Here, “behavior” includes people’s knowledge, perceptions, and attitudes.
A wide range of modalities are considered as potential interventions, including the delivery of medical care and support (e.g., research on psychosocial approaches and methods of care delivery), communication between patients and healthcare professionals, decision-making support, nursing and caregiving, rehabilitation, food and nutrition, employment, physical activity, psychotherapy, and psychological experiments.
Outcomes are examined from various perspectives, including health outcomes such as emotional distress, suicide, physical symptoms, and quality of life (QOL); behavioral indicators such as patient safety, biological responses, response counts, and implementation rates; and patient-reported outcomes (PROs), such as self-efficacy and perceived adjustment.
The Psychosocial and Survivorship Care Group actively supports interventional research that can contribute to innovations in medical care and support that address people’s psychological and emotional well-being.
|
Dissemination and Implementation Sciences/ Diversity and Surveillance |
|
Implementation sciences is an interdisciplinary academic field that develops, verifies, and builds a body of knowledge on methods to incorporate and establish evidence-based interventions effectively and efficiently into routine health care. It involves the collaboration of multilevel stakeholders, such as patients, health care professionals, workplaces, communities, and governments. J-SUPPORT recognizes the necessity of implementation sciences and has been providing support for implementation sciences in a broad range of fields, outside oncology, since 2018. Based on these activities, implementation sciences have developed in a cross-disciplinary manner, also including international health. In 2019, the National Center Consortium in Implementation Science for Health Equity (N-EQUITY) was established with the support of the Japan Health Research Promotion Bureau (JH) (https://www.ncc.go.jp/jp/icc/behav-sci/n-equity/index.html). Since 2021, N-EQUITY has moved forward with implementation sciences support for J-SUPPORT research, and research is being promoted with the aim of strengthening the network. Surveillance support refers to continuous support of the evaluation of the current state of palliative care, observational studies, and requirements for the development of supportive care. |
Last update: September 7, 2026


